Abstract:In this study, we aimed to construct an effective and safe oncolytic adenoviral vector for cancer treatment with gene therapy. First, the promoter of the catalytic subunit of human telomerase (hTERTp), adenovirus early region 1a gene (E1A) and thymidine kinase gene of human herpes virus type 1 (HSV-1-TK) were amplified by using PCR from genomic DNA of 293A cells and wild-type HSV-1 (wHSV-1). These specially-prepared elements were inserted into an adenoviral shuttle vector in the opposite and the same directions of left inverted terminal repeat (L-ITR), respectively, to construct pENTR-E1A-IRES-TK-hTERTp (pEITH) and pENTR-hTERTp-E1A-IRES-TK (pHEIT). LR reaction between adenoviral shuttle vectors (pEITH and pHEIT) and the backbone vector DEST was carried out to establish adenoviral expression vectors pAd-E1A-IRES-TK-hTERTp (pAd-EITH) and pAd-hTERTp-E1A-IRES-TK (pAd-HEIT). Recombinant adenovirus Ad-EITH and Ad-HEIT were produced by transfecting 293A cells and purified for the subsequent studies of titer measurement, replication capability with and without acyclovir (ACV) and antitumor ability with and without ganciclovir (GCV) to evaluate the biological characteristics. Adenoviral shuttle vectors pEITH and pHEIT and expression vectors pAd-EITH and pAd-HEIT were successfully constructed, and recombinant adenoviruses Ad-EITH and Ad-HEIT with high titer were produced. The results of replication and cytotoxicity assays showed that Ad-EITH and Ad-HEIT replicated in the hTERTp (+) human nasopharyngeal carcinoma cell line CNE and expressed the TK gene effectively leading to the death of tumor cells. In addition, there were still some Ad-HEIT particles replicating in the hTERTp (-) human osteosarcoma U-2OS cells and human lung HFL-1 fibroblasts compared to Ad-EITH which was hardly able to replicate in U-2OS and HFL-1 cells. In addition, we also observed an interesting phenomenon, that the replication of Ad-EITH could be inhibited by antiviral drug ACV on account of the expression of HSV-1-TK gene making Ad-EITH sensitive to ACV. In conclusion, a novel oncolytic adenoviral vector Ad-EITH was produced which can be used for cancer-specific and efficient viral replication, and its safety is potentially improved as replication can be inhibited by ACV in vitro.

Construction of Adenoviral Vector for Fcy1 Driven by Htert Core Promoter Modified with MYC-responsive Elements

Construction of Transcriptional Targeting Replication-Defective Recombinant Adenoviruses Containing FCY1 Driven by Modified Htert Core Promoter

Construction of Htert and Cox-2 Dependent Oncolytic Adenovirus

Construction of CNHK500,a conditionally replicating adenovirus driven by the human telomerase reverse transcriptase promoter and hypoxia response promoter

Construction of Tumor-specific Oncolytic Adenovirus Vector and its Primary Study on Selective Expression in Tumor Cells

Construction of a Novel Oncolytic Adenoviral Vector and Its Biological Characteristics

Study of construction hTERT core promoter modified by OSE2 in osteosarcoma transcription target gene therapy

Construction of Antisense RNA Expression Vector of the Regulation Region of Htert Using the Adnovirus System by Homorecombination in E.coli.

Construction and Packaging of a Recombination Adenovirus Expressing Human Telomerase Reverse Transcriptase(htert) Gene

Construction and Identification of Recombinant Adenovirus Vectors Expressing GFP and Human TERT-VEGF-Bcl-xl Short Hairpin RNA

Expression Activity of Cancer-Specific Adenovirus Vector Targeting Telomerase

Construction and Identification of Conditionally Replicative Adenovirus under the Control of E2F1 Gene Promoter

Construct an Adeno Virus Vector Containing an Aiming Gene m4-1BBL Drived by mTERT Promotor

Construction of Recombinant Adenovirus Containing Cytosine Deaminase Gene Driven by Human Telomerase Reverse Transcriptase Promoter

Construction and Identification of the Adenoviral Vector with Dual Reporter Gene for Multimodality Molecular Imaging

[Construction of Recombinant Adenoviral Vector Containing Gene of EWS-FLI1 and Antitumor Immunity of Its Modified Dentritic Cell in Vitro].

Construction and Identification of Mouse Telomerase Reverse Transcriptase Recombinant Adenovirus Vector

CONSTRUCTION AND IDENTIFICATION OF hTERT cDNA RECOMBINANT ADENOVIRUS EXPRESSION VECTOR

Construction of a More Effective Conditional Replication-Competent Adenoviral Vectors Targeting Liver Cancer and Its Cancerostatic Effect in Vitro

Construction of tumor-specific proliferation-deficient adenovirus vector and its primary study on selective expression in tumor cells

Construction and Expression of Bicistronic Adenovirus Vector Carrying Thymidine Kinase and Enhanced Green Fluorescent Protein Gene.